Article

Financing helps patients afford refractive surgery

Costa Mesa, CA—In an effort to retain patients who need to finance their refractive surgery, CareCredit, a division of GE Consumer Finance, is offering 95% approval rates through its CareCreditPlus program.

Costa Mesa, CA-In an effort to retain patients who need to finance their refractive surgery, CareCredit, a division of GE Consumer Finance, is offering 95% approval rates through its CareCreditPlus program.

The program approves more patients than most-including patients with less-than-perfect credit who might not otherwise afford refractive surgery, said Tony Seymour, vice president of client development for CareCredit.

According to the company, an independent survey found financial concerns were the primary reason patients failed to attend their scheduled appointment. The program is designed to be easy for practice administrators to integrate into their practices and expands the client base.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.